PROTESTORS
RALLY AGAINST REGULATION OF HEALTH PRODUCTS
HEALTH-REGULATION-RALLY 766 words Dec 12th 2006 4:00pm Politics/Politics
Wellington, Dec 12 NZPA - About 100 people rallied at Parliament
today to
protest Government moves to set up a trans-Tasman agency
to regulate
therapeutic products.
The Government has struggled for years to muster support
to ratify a treaty
with Australia setting up the regulator, but recently won
the backing of
United Future and NZ First to get legislation past its first
reading to a
select committee for consideration.
Therapeutic products to be regulated by the joint agency
include medicines,
medical devices, and complementary healthcare products.
However many producers of complimentary medicines say a
tighter regulatory
regime would impose big and unnecessary costs.
Protesters today communicated that view to numerous MPs
who attended their
rally.
Natural Health Labs director Mike Cushman told NZPA the proposed
changes
would impose about $500,000 in costs on his business, which
manufactures the
"Clinicians" range of vitamins.
Most companies in the sector were small -- employing less
than five workers
-- and tighter regulation would put many out of business.
He said there were few problems with complimentary medicines
manufactured in
New Zealand and imposing "pharmaceutical-level" controls
were unnecessary
and would limit consumer choice.
Green MP Sue Kedgley told protestors
the legislation was "sinister" and
would cede regulatory control of New Zealand's industry to
Australia.
The regulating agency would be based in Australia and would
be headed and
staffed by Australians who would have powers to impose new
regulations
without any kind of parliamentary vote, she said.
National, Act and the Maori Party also oppose the legislation.
Ms Kedgley said the bill only had enough support to pass
its first reading
because NZ First leader Winston Peters had reversed his party's
opposition
to the bill.
But a fired up Mr Peters told the rally NZ First had won
significant
concessions, including New Zealand and Australia having equal
say on the
regulations.
Under previous drafts New Zealand would have only had one
vote, while
Australia would have had one for each of its states and territories.
Under pressure from hecklers who called
out "traitor",
Mr Peters said some
form of regulation was necessary to weed out "snake
oil merchants" making
outrageous health claims about their products.
Having a strong regulatory framework would also enable local
producers to
export their goods into other markets.
NZ First would make a final decision on which way they would
vote after
public submissions to Parliament's local government and administration
select committee, he said.
State Services Minister Annette King, who is overseeing
the legislation,
later told reporters the protesters were a vocal minority.
Companies which manufactured 80 percent of the locally made
products
supported the move which would weed out rogue traders and
make their
products more marketable overseas.
"They want their products to
be safe. They don't want New Zealanders to buy
a product and then find out it's got grass clipping in it,
or lead, or
viagra, which is some of the things we've found in some complementary
medicines in New Zealand over the last few years."
Ms King said the regulations had not stifled growth in the
sector in
Australia.
The Government had agreed to pay half the cost of regulation
and the new
rules would be phased in over five years.
United Future leader Peter Dunne said he was supporting the
Therapeutic
Products and Medicines Bill to select committee so all the
arguments for and
against could be put on the table, but his party's MPs were
reserving their
final decision.
Prime Minister Helen Clark yesterday said if the bill was
to fail it would
raise questions about how further talks on regulatory integration
with
Australia could take place in the future.
NZPA PAR gf ob
THERAPEUTICS BILL PASSED
FIRST READING IRN-RALLY-PAREGIMES 145 words Dec 12th 2006
6:10pm Politics/Politics
Therapeutics Medicine Bill passed first reading in Parliament
by 61 votes to 60; National's Tony Ryall says it will harm
NZ business
Parliament has passed the first reading of the Therapeutics
Medicine Bill by the narrowest of margins.
It has scraped through by 61 votes to 60.
National Party Health spokesman Tony Ryall says the regulation
will be costly and restrictive and will harm New Zealand
businesses.
He says there should be regulation of therapeutic products,
but not such a bureaucratic regime.
Natural Health Laboratories executive director Michael Cushman
is also warning of dire consequences if the Bill is passed
into law. He says the legislation will drive small companies
out of business and lead to a loss of innovation.
He says over 95 percent of New Zealand companies employ
fewer than six people and the cost imposed by the regulation
will simply kill them.
GREENS ACCUSED OF DECEIVING
PUBLIC IRN-RALLY-PACONTROLS 124 words Dec 13th 2006 5:30am
Politics/Politics
State Services Minister Annette King claims Greens spreading
disinformation over claims about Therapeutics Medicine Bill
The Green Party is being accused of deceiving the public
over The Therapeutics Medicine Bill.
The proposed legislation seeks to create a joint trans-Tasman
scheme for the regulation of therapeutic products, such as
medicines, medical devices and dietary supplements.
State Services Minister Annette King is accusing Green MP
Sue Kedgley of spreading disinformation with her claims the
legislation will see Australia calling all the shots. She
says the new authority would be based in both New Zealand
and Australia with head offices in Wellington and Canberra.
Parliament has voted 61 votes to 60 in favour of the legislation
and the bill will now go to the Select Committee stage.
BILL GOES TO SELECT COMMITTEE
FOR SCRUTINY HEALTH-REGULATION-D/L 927 words Dec 13th 2006
5:01am Politics/Politics
Wellington, Dec 13 NZPA - New Zealand First says it gained
concessions before agreeing to help send a bill setting up
a new trans-Tasman regulatory regime for medicines, medical
devices and complementary health products to a select committee
for scrutiny.
Under the new regime, a joint Australia/New Zealand agency
will regulate therapeutic products.
Legislation on the new regulatory scheme was debated in Parliament
yesterday, after about 100 people rallied on Parliament's
grounds to protest the Government's moves to set up the regime.
Many producers of complementary medicines have complained
the tighter regulatory regime will impose large costs on
their businesses, with some saying they will face bills of
many thousands of dollars.
Natural Health Labs director Mike
Cushman told NZPA the proposed changes would impose about
$500,000 in costs on his business, which manufactures the "Clinicians" range
of vitamins.
Most companies in the sector were small -- employing less
than five workers -- and tighter regulation would put many
out of business.
He said there were few problems with
complementary medicines manufactured in New Zealand and
imposing "pharmaceutical-level" controls
were unnecessary and would limit consumer choice.
New Zealand First had previously opposed the legislation
but its leader Winston Peters said it had won significant
concessions, including New Zealand and Australia having equal
say on the regulations.
Under previous drafts New Zealand would have only had one
vote, while Australia would have had one for each of its
states and territories.
Under pressure from hecklers at the
protest rally who called out "traitor", Mr Peters said some form of regulation was
necessary to weed out "snake oil merchants" making outrageous
health claims about their products.
He lobbied to get a 50 percent subsidy on the cost of registering
products under the new regime.
United Future leader Peter Dunne said there were issues that
needed to be "teased out" during the select committee stage
which was why his party was supporting the bill's first reading.
But National health spokesman Tony
Ryall said Food Safety Minister Annette King had "bought off" United
Future and NZ First support with the 50 percent subsidy.
That had been the only way to garner enough parliamentary
support to progress the legislation, he said.
Ms King yesterday said the joint regulatory
scheme would "cover
the regulation of the manufacture, supply, import, export
and promotion of therapeutic products", as well as set standards
over the quality and performance as well as post-market monitoring
of therapeutic products.
She said responsibility for regulating aspects of the therapeutic
products would be transferred from Medsafe New Zealand to
a new agency, the Australia/New Zealand Therapeutic Products
Authority.
Ms King said there had been uninformed and misleading rhetoric
about the place of complementary medicines and medical devices
in the scheme.
Regulation of medical devices and complementary medicines
in New Zealand was minimal.
Complementary medicines were popular with many consumers
and often perceived to be a safe and natural alternative
to conventional medicine.
"But they are not risk free," Ms King
said.
They could include harmful ingredients, adulterated products,
there could be poor quality control during manufacture,
interactions with other medicines -- for instance, interactions
between St John's Wort and several prescription medicines
-- and inadequate information to guide safe use.
Ms King told reporters after the rally that the protesters
were a vocal minority.
Companies which manufactured 80 percent of the locally made
products supported the move which would weed out rogue traders
and make their products more marketable overseas.
"They want their products to be safe.
They don't want New Zealanders to buy a product and then
find out it's got grass clipping in it, or lead, or viagra,
which is some of the things we've found in some complementary
medicines in New Zealand over the last few years."
Green MP Sue Kedgley kept up her fight
against the trans-Tasman agency, saying New Zealand was
transferring power over dietary supplements, medicines
and medical devices to an "offshore
entity".
She told the protesters the legislation
was "sinister" and
would cede regulatory control of New Zealand's industry to
Australia.
The regulating agency would be based in Australia and would
be headed and staffed by Australians who would have powers
to impose new regulations without any kind of parliamentary
vote, she said.
The Therapeutic Products and Medicines Bill was sent to
a select committee for scrutiny on a vote of 61 to 60. Labour,
NZ First, United Future and the Progressive Party voted for
the bill while National, the Greens, the Maori Party and
ACT voted against it.
NZPA PAR sje ob
12
Dec 2006
Winston looses the plot at Natural
Health Protest
Tuesday, 12 December 2006, 4:43 pm Press Release: NZ Health Trust
12 December 2006
For immediate release
Winston looses the plot at Natural Health Products protest
at Parliament
There were dramatic scenes outside Parliament today as NZ
First leader Winston Peters was verbally attacked and shouted
down by a group of enraged people at a protest rally.
Several hundred natural health product supporters met to
protest the first reading of the Therapeutic Products and
Medicines Bill, which would see control of the sector given
to an Australian agency.
Despite telling the media 6 weeks
ago that he had “stopped” the
Bill, Mr Peters and New Zealand First today voted with the
Government to send the Bill to Select Committee.
Amy Adams, spokesperson for the NZ Health Trust pointed
out the issue had already been to Select Committee twice,
and had been thoroughly rejected on both occasions.
“Everyone except the Government
acknowledges that the Bill will be bad for New Zealand.
It would devastate the local industry, push prices up for
many products while seeing other products removed from
the shelves.”
At the protest the Maori Party announced
its unconditional opposition to the Bill, to the crowd’s
delight, but Mr Peters was booed, shouted down and finally
had to be removed from the microphone.
“Winston knows he has broken his word, and getting
angry with the media and the public attending the rally was
not constructive,” Mrs Adams said.
The Hon Tony Ryall representing National, Sue Kedgley form
the Greens and Hone Harawira from the Maori Party addressed
the crowd, as did Mike Cushman from Natural Health Laboratories
NZ about the disastrous effect the Bill would have on his
business.
ENDS
12
Dec 2006
Oral health the issue? Let's talk fluoridation
Tuesday, 12 December 2006, 10:05 am Press Release: New Zealand Government
Hon Pete Hodgson
Minister of Health
12 December 2006 Media Statement
Oral health the issue? Let's talk fluoridation
New Zealanders voicing genuinely held concerns
about diet drinks and tooth decay should join the Labour-led
government's call for the expansion of fluoridated water
supplies, Health Minister Pete Hodgson said today. read full
article... http://www.scoop.co.nz/stories/PA0612/S00226.htm
12th
Dec 2006
Kiwis will suffer from ban on Chinese
Medicine
Tuesday, 12 December 2006, 10:14 am Press Release: Association of Chinese Medical
Herbalists
NEW ZEALAND ASSOCIATION OF CHINESE MEDICAL HERBALISTS -
NZACMH
MEDIA RELEASE
Kiwis will suffer in new bill that bans Chinese Medicine
Tuesday 12 Dec 2006
Today the ANZTPA bill will have it's first
reading in parliament. These new laws aim to regulate the
natural health products industry. Instead they favour the
commercial interests of the establishment and aim to restrict
and outlaw much of the flourishing complementary health industry.
With our failing health system, many kiwis are turning to
centuries old medicine and paying privately for their healthcare.
This new system will outlaw many herbal products currently
in use, despite no deaths and very few adverse reactions.
As a result many kiwis will be driven back to the sinking
ship of the public health system. read full story... http://www.scoop.co.nz/stories/PO0612/S00152.htm
11th
Dec 2006
GOVT
TO TEST SUPPORT FOR TRANS-TASMAN DRUG AGENCY
HEALTH-REGULATION Dec 11th 2006 7:26pm Politics/Politics
________________________________
Wellington, Dec 11 NZPA - The Government is going to test the
waters and see if there is parliamentary support for legislation
setting up a joint Australia/New Zealand regulator for therapeutic
products.
Prime Minister Helen Clark said today that New Zealand First
and United Future had agreed to support a bill on the subject
to select committee.
New Zealand has not yet ratified a treaty between the two countries
setting up the trans-Tasman regulator, because Labour has been
unable to garner enough support across the political spectrum.
Some parties have concerns about the possible cost and fears
that New Zealand's interests might not be protected.
Therapeutic products to be regulated by the joint agency include
medicines, medical devices, and complementary healthcare products.
The concern most publicly debated is the inclusion of complimentary
medicines in a tighter regulatory regime.
Miss Clark said she hoped that the agreement with NZ First
and United Future to allow the bill to proceed to select committee
and submission would see some parties persuaded towards it
merits.
"The Government regards the trans-Tasman agency as a very important
development in terms of trans-Tasman regulation," Miss Clark
said.
It was part of a wider strategy to harmonise regulations between
the two countries to make it easier to do business across borders.
"This treaty is a very early example of that.. and unless complimentary
medicines are in this treaty cannot stand and that would be
a very adverse development for the overall agenda of deepening
economic co-operation and integration."
If New Zealand's Parliament was to fail at this stage it would
raise questions about how further talks on integration could
take place in the future.
Miss Clark said it was a "source of some bemusement" to her
that National had refused to give the treaty its support despite
the generally bi-partisan approach to trans-Tasman regulation.
NZPA PAR il kk ob
Source: NZPA Parliament
Credit: NZPA #2635787
10
Dec 2006
Therapeutic
Products Bill Press Release by New Zealand Charter
Of Health Practitioners at 2:58
pm, 10 Dec 2006
Important questions that the Press, Members of Parliament and
New Zealand Electors should be asking regarding the Therapeutic
Products Bill
Why Dietary Supplements should be 'Removed completely from
the Therapeutic Products Bill' at the 'First Reading'
New Zealand Health Industry Practitioners Totally Reject the
Australian Take Over of the New Zealand Dietary Supplements
and HealthCare Industry with the introduction of the Therapeutic
Products Bill, which is the sanitised name for the infamous
Trans-Tasman Joint Therapeutic Agency Treaty that has been
overwhelmingly rejected by all sections of the New Zealand
HealthCare Industry.
This Bill is the working part of a Treaty which will surrender
full and total control of our Health Care to an Australian
corporate body that is inferior to New Zealand's standard of
Health Care - where is the advantage to New Zealand? There
is none! - In Fact it requires three years to opt out of the
Treaty once it is found to be detrimental and undermine New
Zealand's health status.
Four years ago the New Zealand Health Industry presented Medsafe
with a low-cost, economically viable, full recovery regulatory
system, acceptable to the entire New Zealand industry. Incomprehensibly
this project was abandoned by Medsafe in favour of the Australian
regime.
WHY??? Possibly the statement made by Susan Martindale the
Joint Agency Team Leader for New Zealand with the Australian
regime New Zealand Medsafe members of the Joint Agency would
be on the same elevated pay scale as their Australian counterparts
and would also benefit from the exchange rate difference sheds
some light on one reason why.
Excessive Costs
The Joint Agency, it has been reported at an Auckland consultation
meeting will cost New Zealand One Hundred and Twenty Five Million
Dollars ($125,000,000) for the first year of operation.
For unsubstantiated reasons (especially when considering the
costs stated above - which was kept hidden at the time), Medsafe
informed the Health Select Committee that it would be too costly
to implement a New Zealand regulatory system; totally ignoring
the fact that the system presented by the Health Industry for
registration of products would be minimal when compared with
the overpriced Australian adventure.
An example of the high cost Australian Therapeutic Goods Authority
(TGA) product registration of a simple anti-oxidant (that is
already registered in the European Union) would require an
additional Australian registration fee of Two Hundred Thousand
Dollars plus compliance costs before it could be marketed in
Australia.
The above is just the tip of the TGA nightmare.
ENDS
9th
Dec 2006
Medicine bill axes proposal
to ban TV ads
09 December 2006
By KAMALA HAYMAN
Television advertisements for prescription medicines
will not be banned by law, disappointing public health campaigners
and some doctors.
A parliamentary bill, tabled this week, has raised concern
among groups fearing it will damage New Zealand's natural
health products industry.
The proposed Therapeutic Products and Medicines Bill would
set up a trans-Tasman regulatory regime for all medicines,
medical devices and alternative health products.
It would also establish the joint Australia New Zealand
Therapeutic Products Authority.
The bill, expected to have its first reading next week,
had been expected to curtail the advertising of prescription
medicines.
However, widespread political opposition has forced Labour
to scrap any attempt at a ban. read full story...
Hon Tony Ryall
National Party Health Spokesman
07 December 2006
Therapeutic Bill a bureaucratic nightmare
National’s Health spokesman, Tony
Ryall, is attacking Labour’s decision to push ahead with
a trans-Tasman agency to regulate natural healthcare products.
Mr Ryall’s commenting after the
tabling of the Therapeutic Products and Medicines Bill.
National is opposing the Bill. "We are not prepared to jeopardise the
viability of hundreds of small businesses nor the choices
of thousands of consumers. This regime will be costly,
restrictive and is unnecessary.
"It's a move that's going to cost industry
and consumers. The Australian natural health products industry
is one of the most highly regulated in the world, and applying
its rules here will only serve to increase the cost of
products, reduce consumer choice and hurt many businesses.
"There should be regulation of natural
health products but not this bureaucratic nightmare. “The fact that the Labour Government
has had to offer a 50% subsidy to garner parliamentary
support proves this regime is too expensive." Ends
Inquiries: Tony Ryall 021
953 024
7
Dec 2006
Parties give backing for transtasman
drug agency
Thursday December 7, 2006
By Ruth Berry
The Government's support parties have ditched their opposition
to the establishment of a transtasman drug agency, despite
their failed attempts to get dietary supplements and other
complementary medicines excluded.
The Government signed a treaty in 2003 with the Australian
Government agreeing to the agency, that would replace MedSafe
and regulate medicines and medical devices, but has been unable
to get the political support to pass enabling legislation.
Wednesday, 6 December 2006, 10:33 am Press Release: NZ Health Trust
Media release
For immediate release 06 December 06
Government sneaks Bill into House to avoid public backlash
Despite unprecedented political opposition, the Government
has forged ahead with the Therapeutic Products and Medicines
Bill, sneaking it into the House without any of the usual
fanfare.
In 2003 Minister Annette King signed a Treaty with Australia
agreeing to hand control of the natural health products sector
over to an Australian regulatory body, however she needs
to pass enabling legislation in New Zealand.
Twice the Bill has been thrown out by select committees,
but the Government is determined to ram it through Parliament,
said consumer group the New Zealand Health Trust.
Wednesday, 6 December 2006, 3:07 pm Press Release: Green Party
NZ First stakes reputation on controversial legislation
New Zealand First's reputation will be in tatters on Tuesday
if Winston Peters reneges on his public commitment to stop
the establishment of a trans-Tasman regulatory agency that
includes dietary supplements.
Just over a month ago Peters promised on Radio New Zealand:
'For those people that believe in natural medicines, they
(NZ First) have stopped the therapeutic bill that would have
included all natural medicines being run by a trans Tasman
agency. That's stopped.'
"However, the Greens understand that far
from stopping the bill, New Zealand First will be supporting
it when it is introduced into Parliament next Tuesday," Green
Party Health Spokesperson Sue Kedgley says. read full story... http://www.scoop.co.nz/stories/PA0612/S00111.htm
5
Dec 2006
The government has tonight
(Tuesday 5 Dec 06) tabled the ANZTPA bill with absolutely
no announcement or advance warning.
The Bill is 494 pages and Natural Products are definitely
included.
New Zealand First is languishing in the
polls and wants more support from young people. Winston explains
some of the good things that NZ First has achieved which
includes ;
winston
Short 55 sec version
”For those people that
believe in Natural Medicines, they (NZ First) have
stopped the Therapeutic Bill that would have included all Natural
Medicines being run by a Trans Tasman Agency. That's Stopped”!!
Full Version
From Checkpoint on 20 Oct 06, click on Focus
on Politics.
If you have Windows Media Player you should be able to listen
to the audio.
BRITISH CANCER DOCTOR CALLS FOR COMPLEMENTARY
MEDICINES TO BE REGULATED LIKE DRUGS
In the latest British Medical Journal,
a British Professor of Oncology launches an all-out attack
on complementary therapies, especially for cancer patients,
and calls for all complementary medicines to be reclassified
and regulated as drugs. He argues that alternative medicine
is ‘big business, with a UK market value of 250
million pounds, increasing by 7% a year.’
After insisting that once cancer is
diagnosed no change in diet will lead to any improvement
in cancer outcomes, he calls for legislation to subject
all alternative medicines to the level of scrutiny pharmaceuticals
undergo. “Reclassify these agent as drugs—for
this is after all how they are marketed—and protect
our patients from vile and cynical exploitation whose
intellectual basis, at best, might be viewed as delusional.’
May I take this opportunity to wish
you all a wonderful Christmas and New Year. I hope you
will all get a much needed break and will start the new
year refreshed and enthusiastic.
Regards
Sue Kedgley
Green Party of Aotearoa New Zealand
23
Nov 2006
Australian
Govt launches alternative medicine study Herbal and other alternative medicines
are about to be put to the test, with the federal government
committing $5 million to determine whether they really
work.
Australians spend about $1 billion each
year on complementary medicines including vitamins, homeopathic
medicines and traditional Asian and indigenous medicines.
Americans Surprised, Concerned
that 90% of Flu Shots Contain Mercury
Health Officials' Aggressive Flu Shot Campaign May Disregard
Safety, According to Survey of 9,000 Americans
74 Percent of Respondents Unaware Flu Shots Contain Mercury,
78 Percent Disagree with CDC About Vaccinating Pregnant
Women and Children
PRNewswire, Nov 13, 2006 Straight
to the Source
PORTLAND, Ore., Nov. 13 /PRNewswire/ -- As health officials
step up their effort to vaccinate Americans against the flu,
a new survey suggests serious concerns over the toxin mercury,
an ingredient in over 90 percent of this season's flu shot
supply. PutChildrenFirst.org, a parent-led organization advocating
vaccine safety, commissioned a survey of over 9,000 Americans
to learn their plans for getting flu shots, their knowledge
of its ingredients, and who they hold responsible for making
sure vaccines are safe.
The survey revealed that the overwhelming majority of Americans
were unaware that most flu shots contain mercury and that they
would refuse a shot with mercury.
6
Sep 2006
Nutricide -
Criminalizing Natural Health, Vitamins, and Herbs
The Codex Alimentarius is a threat to the freedom of people
to choose natural healing and alternative medicine and nutrition.
At the same time while Norwegian authorities were
paying compensation to vaccine victims, the same vaccine
was exported to New Zealand and used on small kids. To
say it nice, they enlisted hundreds of thousands of small
kids into a gigantic experiment, says Jan Helge Solbakk,
professor in medical ethics.
1988 started the largest experiment ever conducted on Norwegian
population. 180,000 school teenagers were used as test subjects
in the largest Norwegian vaccine trial ever. It lasted from
1988 to 1991.
Norwegian Institute for Public Health was testing it's new
vaccine against meningococcus b, dangerous bacteria that
kills 30 people every year in Norway.
The information brochure given to
teenagers states: " it
is unlikely to expect serious complications ",
while the information submitted to the Norwegian Parliament
states: " serious side effects can not be excluded " during
the experiment.
Jan Helge Solbakk, professor of medical ethics - Foto: TV
2
Jan Helge Solbakk, professor of medical
ethics, was working on the ethical sides of the trial.
He claims: "project leaders
knew that trial subjects may suffer serious complications
during the trial, statistically speaking."
"Trial subjects were not properly informed about the possibility
of serious side effects during the trial. We encouraged the
project leaders, during an open meeting, to do it in a better
way, informative way" says Solbakk to Dokument 2.
- 512 side effects were reported during the vaccine trial.
- 14 were considered serious.
- 5 school kids developed serious neurological diseases.
During the second trial, involving 53,000 kids, 10 serious
side effects were reported, while 1 child developed serious
neurological disease.
Worried about the side effects
Hans Cato Guldberg, professor of medicine,
was a member of a committee that was to evaluate side effects
during the experiment. He was worried.
"Some time after the experiment was over, I came to a conclusion
that there were serious side effects to this vaccine. And,
the number was relatively high. I was worried. At
the same time, I felt that project leaders were trying to
tone down the danger of vaccine, said Guldberg.
Results of the vaccine trial were
compiled 1991. Vaccine
was providing protection in 57% of cases. That was
not enough to add it to the Norwegian vaccination program. As
meningococcus b epidemic was dying out, vaccine was never
used in Norway the way it was meant.
Foto: TV 2
After the request from the World Health
Organization (WHO), vaccine was exported to New Zealand,
during 2001. Using
the same technology and the same methodology from 1980s,
researchers from the Norwegian Institute of Public Health
tailored a new vaccine for New Zealand. The multi-national
pharmaceutical company Chiron was awarded
rights to mass produce the vaccine.
Usually, vaccine is supposed to pass
different tests before it is approved for mass use on population. But this
vaccine was tested in a record short time. Phase III
trials were totally dropped. Rare side effects are
often not discovered before the phase III trials. Phase
III trials are randomized, placebo controlled trials. Instead
of testing this new vaccine through a new phase III trial,
safety data and affectivity data were just taken from the
Norwegian vaccine and assumed valid for the New Zealand vaccine. Because
safety data of this vaccine was incomplete, the vaccine was
not officially approved on New Zealand. Instead, mass
vaccination of 1.1 million New Zealand kids started with
a temporary approval.
Breach of the international research ethics
In New Zealand, the Norwegian vaccine was used as guarantee
that the New Zealand vaccine is safe and effective. It was
the Norwegian Institute of Public Health that was the guarantor.
"First: Norwegian vaccine was not safe! Second, it is a
serious overstatement to say that vaccine is effective. Third:
it is against international regulations and against research
ethics to start to vaccinate small children on New Zealand
with a vaccine that was tested on a different group of people,
Norwegian school kids. To say it nice, they enlisted hundreds
of thousands of small kids into a gigantic experiment," says
Jan Helge Solbakk, professor in medical ethics."
Quote: "Some time after the experiment
was over, I came to a conclusion that there were serious
side effects to this vaccine. And, the number was relatively
high. I was worried. At the same time, I felt that project
leaders were trying to tone down the danger of vaccine."
Hans Cato Guldberg, professor of medicine, was a member
of a committee that was to evaluate side effects during the
experiment.
13
Oct 2006
Natural medicines – the
safest way to avoid death
A report just released by the Acting
Chair of the Coroner’s
Council has shown natural medicines have the lowest fatality
rate of all medical treatments in this country.
Despite extensive research, coroner Dr Wallace Bain found no
deaths have occurred in this country due to natural medicines
such as vitamins, minerals and herbal products. Click
here for the PDF.
21
Sep 2006
Probe on vitamins from GPs The Australian: by Matthew Franklin
21sep06
THE consumer watchdog will be asked to investigate claims that
doctors are exploiting
their patients by buying vitamins at wholesale prices and selling
them on for massive
profits. Click
here for the PDF.
21
Sep 2006
Australia
inquires into GPs’ sale of
complementary
medicines from bmj.com news roundup
An ethical debate has arisen
among doctors in Australia
after the federal government
announced plans to investigate
the sale of complementary
medicines by GPs. click here for the PDF
Vaccination -
The Hidden Truth (1998) - on Google Video
Health Canada betrayed
trust Canadians needlessly suffered and died as a result of decision Calgary Sun,August 20, 2006
By Licia Corbella
If it's true that Health Canada's mandate is to protect the
health of Canadians -- as its name suggests -- then the federal
government needs to call an inquiry into the disgraceful
and deadly actions of this agency. read
PDF article
18 Aug 2006
NDPSC FORESHADOWS
DECISION TO SCHEDULE GLUCOSAMINE Sulfate Potassium Chloride
Complex - S4 (Prescription only) The National Poisons and Drugs Scheduling Committee (NDPSC)
last Friday foreshadowed a decision to schedule as prescription
only Glucosamine Sulfate Potassium Chloride Complex (D-Glucosamine
Sulfate -2KC1) products based on the potential for inadvertent
overdosing due to the potassium content. The primary basis
for the scheduling proposal is the overdose death of a child
from ingesting of slow release potassium chloride tablets.
CHC is extremely concerned about the potential
impact of this scheduling proposal on the complementary healthcare
industry, should it be confirmed. Immediate action has been
taken to address this enormous threat to our members and
many have been contacted to assist with the gathering of
information to establish our case to not proceed with the
foreshadowed scheduling.
Discussions have been held with TGA and we
have provided data to assist them in addressing the issues
raised by the scheduling committee. The TGA have indicated
that they share our concerns with this foreshadowed scheduling
decision.
Please be assured that we are doing everything
possible to achieve a sensible outcome from the committee.
As more information comes available we will continue to update
members.
Submissions are due on this issue by 13 September and the final
decision will occur in October
9 Aug 2006
TRANSTASMAN
AGENCY FOR MEDICINES ABOUT MUCH MORE THAN PILLS Aug 9th 2006 1:30am Newspapers/Nz Herald
On page:
C04
HERE'S a way to get up an Aussie nose: Junk the proposed
joint therapeutics agency. Which would probably get up our
own nose by setting back progress towards the single economic
market (SEM).
Judgment
won today in the Alberta courts against Health Canada
28 July 2006
This is a major victory in Canada for the
use of nutritional products. The trial was won on the basis
of a necessity defense and due diligence.
Read PDF article
We have also attached an article found about the judgment
on the CBC National News site.. Read
PDF article
20 Jul 2006
PQs:
Question 5: Australia New Zealand Therapeutic Products Agency-Legislation
Press Release by Office of the Clerk at 5:42 PM, 20 Jul 2006
Australia New Zealand Therapeutic Products Agency-Legislation
5. SUE KEDGLEY (Green) to the Minister of State Services: Does
the Government still aim to introduce legislation to the House
this month to set up an Australia New Zealand therapeutic products
agency; if not, why not?
Hon ANNETTE KING (Minister of State Services): No.
Consultation on the proposed Australia - New Zealand therapeutic
products agency is ongoing.
Sue Kedgley: Has she seen Australian consultant Val Johanson's
damning report predicting that if New Zealand joins the Trans-Tasman
therapeutic goods agency, compliance costs for natural health
products will escalate, over 50 percent of small dietary supplements
businesses will close down or move offshore, and the cost of
natural health products will significantly increase; and can
she explain why she would want this to happen in New Zealand?
Hon ANNETTE KING: Yes, I have seen that report. I do not agree
with everything in it, but certainly, in terms of the consultations,
we are looking at ways we can ensure that those who make complementary
medicines in New Zealand will not be unduly affected by the
cost of compliance.
Darien Fenton: Has she seen the reports from opponents of the
scheme stating that traditional Ma-ori medicines and healing
would be legislated out of existence; and is this correct?
Hon ANNETTE KING: Yes, I have seen such reports. Their information
regarding Ma-ori and other traditional medicines is wrong.
The authors have been told that is the case, but for their
own purposes they continue to peddle this misinformation.
Barbara Stewart: Does the Minister acknowledge that there has
been significant public opposition to the agency, and that
the establishment of the agency is in doubt because New Zealand
First will not support the accompanying legislation; if so,
for how long does she intend to pursue this rather futile exercise?
Hon ANNETTE KING: I will continue to negotiate a joint regulator
until all the issues have been finalised. It will then be up
to this Parliament whether the proposal is accepted. But I
would note that this regulator and the negotiations around
it have been almost 10 years in duration. They started under
a National Government and continued under this Government for
the very good reason that we are progressing our joint relationship
with Australia. This proposal is seen to be an advance on CER,
which I think it is to the benefit of New Zealanders.
Sue Kedgley: Why has the Government spent $6 million to date
on a project that has never had parliamentary endorsement or
approval, and why will the Minister not admit that she does
not have sufficient support in this House to get the legislation
through, and that she does not have support amongst most people
in the dietary supplements industry; why will she not call
it quits, stop wasting taxpayers' money, and convene a working-group
across all parties in this House to come up with a New Zealand
- based alternative?
Hon ANNETTE KING: Because more than those in the complementary
medicines sector are involved in this joint regulator. I am
certain members of this House have received letters from those
in the pharmaceutical industry who are in favour of it, from
those in the over-the-counter industry who are in favour of
it, from those in the medical devices industry who would like
to see changes but are in favour of it, and from some of those
in the complementary medicines sector who want to see regulation
that protects New Zealanders. What I have not ever been able
to understand from that member is why New Zealanders should
have to put up with this sort of thing happening in this country.
These are herbal medicines, complementary medicines, that have
to be withdrawn from our market because they are not regulated
in New Zealand. These so-called complementary medicines have
in them undeclared prescribed medicines. They have been put
into the so-called complementary medicines, and that is able
to happen because we do not regulate them in this country.
Sue Kedgley: Does the Minister agree with Marcus Blackmore,
head of Blackmores New Zealand, that in Australia regulatory
creep has resulted in a drug-based model of over-regulation,
of unnecessary red tape that is too complex, too costly, and
bears little relation to the public risk involved; and does
she further agree that we should have random testing of all
products in New Zealand under the present legislation, that
all members of Parliament in this House agree that we need
a simple regulatory system that will ensure all complementary
medicines are true to label, and that it should be in existence
now with random testing?
Hon ANNETTE KING: If it were so simple that all one needed
in a regulatory system was a random test, then we would have
a very poor system indeed, because it is exactly what we have
now. The only way these products are detected is by a random
test. What we ought to have is good manufacturing practice
and, in every part of the process, knowledge of what has been
put into the product. That does not occur in New Zealand. We
find out by chance in this country, by a spot audit, not by
products being manufactured in a proper way, as is done in
every First World country around the world.
The evidence the Ministry of Health does not want you to
see.
By Ron Law and Barbara Sumner Burstyn
In this Meningococcal Gold Rush III post-MeNZB(tm) vaccine
update we present fresh evidence revealing apparent scientific
misconduct relating to the recently concluded meningococcal
vaccination program and associated research. ..read full
article. http://www.scoop.co.nz/stories/HL0607/S00284.htm
05 July
2006
POLITICS:
Health regulator mired in MMP mud The Independent Financial Review
- 05 JUL 2006 : Page 005
DONOGHUE TIM
FORMER Health Minister Annette King's planned
trans-Tasman medical safety agency appears destined to founder
on the rocks of MMP politics.
The Australia New Zealand Therapeutic Products
Authority, costing an estimated $A73 million annually, is
due to come into force with the passing of legislation later
this year.
But Green Party MP Sue Kedgley is determined
to ensure King, the minister responsible for setting up the
authority, doesn't get the empowering law through the House.
The agency would merge Australia's Therapeutic
Goods Administration (TGA) and New Zealand's Medicines and
Medical Devices Safety Authority (Medsafe).
Products to be regulated include prescription
and non- prescription medicines, complementary medicines,
medical devices, blood and blood components and tissue and
cellular therapies.
Kedgley, who last month helped sink the
government's attempt to include working farm dogs in microchipping
law, says the new agency is a dead duck.
"They've already wasted $6 million of taxpayers'
money on something which won't get off the ground politically
here," said Kedgley, Parliament's health select committee
chairperson.
The MMP odds are stacking up in Kedgley's
favour with Tony Ryall, for National, Barbara Stewart, for
New Zealand First and Heather Roy, for ACT, stating their
parties will oppose introduction of the legislation.
United Future and the Maori Party are in
talks with King and showing signs of support for the agency.
But even with their support, the measure is unlikely to be
passed.
King said New Zealand could kiss goodbye
to working co-operatively with Australia on other similar
regulatory bodies if Parliament rejected the proposition.
It was "very much in keeping," King said,
with the 1983 Closer Economic Relations agreement and the
Trans-Tasman Mutual Recognition Arrangement of 1996 - agreements
seeking to remove regulatory barriers and facilitate trade
between the two countries.
New Zealand would be required to pick up
$A7.8 million of the annual running tab.
"It's a very good deal for us," King told The Independent
Financial Review. "It's not one for the Nats to play fast
and loose on. If they do, people will remember when it's
their turn in government."
King found herself offside with the majority
of the health select committee when she ploughed ahead with
the joint agency idea, after the committee recommended in
December 2003 she concentrate on establishing a stand-alone
New Zealand agency.
King signed an agreement with the Australian
government in spite of this opposition and that of business
people such as Bill Bracks, who heads health company Comvita.
He says TGA rules are applied to industry in Australia in
a "petty, pedantic way" New Zealanders can do without.
A three-year transition period is proposed,
during which:
* Manufacturers and sponsors must obtain product licences;
* Products must comply with all requirements of the joint
scheme before product licences are granted;
and
* No re-evaluation of products approved under current regulatory
requirements of either country. HEALTH REGULATION
THE trans-Tasman health products authority has been designed
to:
* Regulate "the quality, safety and efficacy or performance
of therapeutic products in Australia and New Zealand"
Products covered:
* Prescription medicines, over-the- counter medicines, complementary
medicines, medical devices and blood
Costs:
* NZ's estimated $7.8 million share of the total costs to
be met from industry
* Some industry lobby groups have opposed the treaty for
offshoring NZ decision-making, adding costs and potentially
driving out some businesses
TIMELINE
SIX years' work towards a trans-Tasman health products regulator:
May 2006
Consultation begins on licensing, rules, fees and charges
Authority will now start "next year"
March 2006
Bills to be introduced to NZ and Australian Parliaments in
July
May 2005
Australia and NZ agree on standards committee
February 2005
Agency will start "next year"
March 2004
Treaty to establish the agency introduced in both Parliaments
December 2003
Both countries sign treaty
March 2001
Health Minister Annette King announces NZ and Australia will
consider joint agency
2000
Consultation on possible framework for agency
28 June 2006
Cabinet
paper reveals secret decision
Documents released under the Official Information
Act to the Green Party reveal that the Government made a
decision to veto mandatory country of origin labelling of
food in secret, without any debate in Parliament or consultation
with any parties in the House, MP Sue Kedgley says.
The government last year unilaterally pulled
out of a joint food standard with Australia that would have
required New Zealand to introduce mandatory country of origin
labelling of food.
Cabinet papers, made public by Ms Kedgley,
show that the Minister of Food Safety, at the time, Annette
King, told the Cabinet Business Committee that in making
its decision ‘consultation is not required with the
government caucuses or other parties represented in Parliament’.
Most remarkably, the largest group of legislators
in the country, the Labour Party caucus, were not even consulted
when the Minister moved to introduce this rift into Trans-Tasman
relations.
“This is breathtaking arrogance and
complete disregard for democracy. It has all the hallmarks
of Muldoonism, with the executive making decisions without
any input from Parliament,” Ms Kedgley says.
“The decision as to whether or not
there is mandatory country of origin labelling of our food
is of vital interest to New Zealand consumers and to many
MPs and parties in the House.
“Yet the Minister decided to ignore
their views, and not to even consult with MPs, but to go
ahead and make the decision in secret.
“She justified her decision by saying
that there is no demand amongst New Zealanders and no consumer
benefit from country of origin labelling. This is outrageous
and completely contrary to independent research which found
that 81 percent of New Zealanders want to know whether their
food is imported or not.
“The Minister justified her decision
by saying ‘it would set a precedent that would be unhelpful
for New Zealand companies internationally’ and ‘would
be a potentially trade restrictive and incompatible with
our WTO obligations’.
“She doesn’t appear to have
considered the interests of consumers in making this decision,
only those of the meat and dairy lobbies,” Ms Kedgley
says.
Ms Kedgley’s Consumer Right to Know
Bill, being considered in the House today, would introduce
mandatory country of origin labelling in New Zealand.
28 June 2006
Numbers
doubtful for transtasman drug agencyWednesday
June 28, 2006
By Ruth Berry
GOVT
PRESSES AHEAD WITH TRAN-TASMAN THERAPEUTIC AGENCY HEALTH-THERAPEUTIC
(carried earlier) 808 words May 23rd 2006 8:42pm Politics/Politics
By Kent Atkinson of NZPA
Wellington, May 23 NZPA -
A health lobby with a history of supporting the lightly-regulated
dietary supplements sector says the Government's plan to hand
over control of the sector to a trans-Tasman therapeutics regulator
is "a terrible idea".
Health Trust spokeswoman Amy Adams said officials were already
planning rules, fees and charges for the proposed agency, but
she feared it would axe access to many of the "natural'
products on this side of the Tasman.
"Australians cannot get many of the therapies New Zealanders
have and many of the ones they can get are ineffective and
expensive," she said.
The Government today announced it was releasing for consultation
documents which will provide a framework for regulation of
medical drugs and devices, through the proposed new Australia
New Zealand Therapeutic Products Authority.
Transitional director of the authority's establishment group
Philip Davies said it was being set up to regulate the safety,
quality and effectiveness of prescription and over-the-counter
medicines, herbal and complementary medicines, medical devices
and blood products in both countries.
Once established, it would replace New Zealand's Medicines
and Medical Devices Safety Authority (Medsafe) and Australia's
Therapeutic Goods Administration (TGA) .
Australia requires all ingredients in dietary supplements to
be approved and licensed, which can cost up to $10,000 per
ingredient.
On this side of the Tasman, New Zealand manufacturers who want
to avoid the costs of registering their edible products as
medicines, call them "dietary supplements", a classification
which allows the products to be sold as long as they are not
sold with therapeutic claims.
The manufacturers sell products such as royal jelly and bee
pollen, herbs, beneficial bacteria, and essential oils under
the Dietary Supplement Regulations 1985, and rely on word of
mouth and postings on the Internet to spread claims that the
products can "cure" illnesses or other medical conditions.
According to one senior health official the NZ regulations
have even been used to allow the sale of an enema preparation
labelled as a "dietary supplement".
Medsafe officials have complained that the Health Ministry
had been unable to police the present rules, and the Foods
Act offered little control over market entry or product quality.
Medsafe initially planned a policy to be approved by August
2002 and new legislation passed by May 2003, and then a new
law to take effect in 2004.
Last December, the Government announced that the trans-Tasman
authority's start-up date of July 1 this year had been delayed
to an unspecified date.
Now, State Services Minister Annette King expects the new regulations
to be introduced in the second half of 2007.
But Mrs Adams said today that if the Australians gained control
of decision-making on natural remedies, it would never be recovered,
and natural therapeutic companies would suffer.
The local industry and New Zealand's Parliament would have
virtually no ability to influence the new agency once it was
established, she claimed.
Mr Davies today called for submissions on the proposed scheme
and argued that it was important to the continued development
of closer economic relations between Australia and New Zealand.
Papers released today include a draft medicines rule regulating
prescription and over-the-counter medicines and complementary
medicines.
Medicines with shared characteristics may be grouped together
on one product licence.
A draft medical devices rule also released covers things such
as contact lenses, condoms, heart valves and pacemakers, hearing
aids, defibrillators and endoscopes.
The closing date for submissions is August 1 and a series of
industry and stakeholder meetings will be held in Australia
and New Zealand during June, with legislation to be introduced
to Parliament in July.
The Green Party has opposed the agency because it fears control
of dietary supplements would be handed to Australians, with
reduced choice and higher prices.
National has previously opposed the authority because Australian
imposed bureaucracy would increase costs for New Zealand business,
and because it would cover dietary supplements.
NZPA WGT kca kk
Source: NZPA Wgtn
22nd May 2006
Consultation over TGA
rules a sham
Consultation by Medsafe over rules for the proposed Therapeutic
Goods Agency is completely meaningless and an attempt to
dupe the industry, according to consumer watchdog group the
New Zealand Health Trust.
Medsafe is holding a top-secret consultation
meeting on Monday afternoon with a small group of supporters
to go over key points such as the proposed rules for natural
health products and medical devices, and proposed fees
and charges. Industry and consumer groups that have opposed
Government’s
plan have been denied entry to the meeting.
The Minister Annette King and officials
are still trying to mobilize support for the proposed Trans-Tasman
agency, despite firm opposition from all other political
parties who are concerned it is not in New Zealand’s
best interests.
“The Government knows it does not have the numbers
to pass legislation to create this agency, however it is
continuing with a costly programme of consultation and preparation
for the new body,” said the NZHT’s Amy Adams.
“What’s more the consultation itself is meaningless,
as the new agency‘s Managing Director could simply
change the rules as soon as it was established,” Mrs
Adams said.
Of enormous concern to the NZ Health
Trust was the fact that the consumers, the local industry
and New Zealand’s
Parliament would have virtually no ability to influence the
new agency once it was established.
“It’s time for the Minister
Annette King to get realistic about the level of opposition
to the proposed TGA and to re-open discussions with the
industry and consumer groups about alternative ways to
regulate this booming sector.”
Ends
8th Apr 2006
This DVD contains a
12 min Q & A interview with Amy Adams (lawyer
and spokes person for NZ Health Trust ) also a 46
min indepth presentation by Amy Adams
"WHY THE PROPOSED TRANS-TASMAN
GOODS AGENCY MUST NOT PROCEED"
AVAILABLE ON DVD NOW THIS IS HIGHLY RECOMMENDED VIEWING
The DVD contains two presentations,
a short 12 min Q&A interview and a 46 min version
by Amy Adams, you can view the 12min version online
by clicking here If you don't have have broadband
or you just want to hear the audio click
here for the 12 minute audio file or
all visitors can click
here for the full 46 audio version.
ORDER
YOUR DVD TODAY Send payment of NZ$10.00 to
NZ Health Trust
PO Box 34057, Fendalton, Christchurch 8030
Please remember to include
your return delivery address details. The
above offer is only available for New Zealand
delivery addresses, Australian subscribers will
need to post us a a cheque for AU$15 for Airmail
delivery, all other requests please contact us by
email using our contact form on the website.
This DVD was produced by NZ Health Trust in association
with New Health New Zealand, it may be copied, distributed
and Broadcast in its entirety free of charge - anything
less than full reproduction or transmission of the
contents requires the approval of the NZ Health Trust
4th Apr 2006
REPORT
BY OCEANIA HEALTH CONSULTING
January 2005 31 pages
REVIEW OF THE NEED FOR FURTHER REGULATION OF EXTEMPORANEOUS
COMPOUNDING.
See item 2 The present legislative Framework in
Australia and 2.1 Constitutional Limitations
of the Therapeutic Goods Act, of this report showing
a very real example of why the TGA is so keen for the trans
tasman body - nothing to do with NZ - more about removing
their constitutional inability to regulate sole traders
and natural persons.
This report demonstrates that the TGA wants to extend its
control to all Territories and states to cover natural people
and reach into pharmacists and hospital controls, all of
which are currently outside their domain.
(Only currently covers 3 of the 8 being NSW, Tasmania, but
to a lesser degree Victoria) Read
the PDF by clicking here
New
Australia-New Zealand Therapeutic Products Authority a step
closer Joint Agency Establishment Group for the Australia
New Zealand Therapeutic Products Authority
ANZTPA will be a joint, trans-Tasman agency with responsibility
for regulating therapeutic products across both countries.
When established, it will replace Australia’s Therapeutic
Goods Administration (TGA) and the New Zealand Medicines
and Medical Devices Safety Authority (Medsafe). read
full article click here
22nd Mar 2006
AUSTRALIA,
NZ COMMITED TO BEGIN JOINT THERAPEUTIC PRODUCTS BODY
SYDNEY, March 22 /
MediaNet International - AsiaNet / - The Australian
and New Zealand Governments met in Sydney recently
and reaffirmed their commitment to an ongoing program
of consultations with key stakeholders and interested
parties leading up to the establishment of the new
Australia New Zealand Therapeutic Products Authority
(ANZTPA).
ANZTPA will replace Australias Therapeutic
Goods Administration (TGA) and the
New Zealand Medicines and Medical Devices Safety Authority
(Medsafe). Click
here to read full story
23rd Feb 2006
Plug pulled
on single Tasman regulator
23.02.06
By Fran O'Sullivan, NZ Herald
The plan for a single regulator to supervise banks on both
sides of the Tasman has fallen prey to New Zealand national
interest sensitivities.
Australian Treasurer Peter Costello and Finance Minister
Michael Cullen have instead announced both Governments will
legislate to ensure their nations' banking supervisors collaborate
on regulatory issues and avoid actions that could affect
the financial stability of either country.
Former
Pan Pharmaceuticals boss sues TGA
February 13, 2006 - 6:59PM
Former Pan Pharmaceuticals boss Jim Selim has launched a
multi-million bid to sue the Therapeutic Goods Administration
(TGA) for money he lost because of the complementary drugs
manufacturer's collapse.
Lawyers for Mr Selim lodged several batches of documents
with the Federal Court in Sydney on Monday, including a claim
for about $140 million. read
full article click here
23rd Jan 2006
TGA rent surges - industry
to pay
Posted 23 January 2006
Occupation of its Canberra headquarters will cost
the Therapeutic Goods Administration an extra $880,000
this year and the pharmaceutical industry will pay.
The considerable and unexpected hike follows a triennial
rent review which lifted the annual cost of the TGA''s Symonston
offices to $6.51 million, a boost of 15.6 per cent. The figure
is made up of $4.65 million in pure rent plus $1.86 million
for amortisation of the laboratory fit-out and other inclusions.
The regulator admitted the size of the increase was unexpected
and had not been factored into its charging regime.
"This is the first market rent valuation undertaken since
the sale of the complex in 2002," a spokesperson said. "The
TGA had not anticipated a significant increase in its lease
to arise from the market rent valuation and had not factored
the increase into current fees and charges."
None-the-less, industry is expected to pick up the tab. "Rent
costs comprise part of the normal operating costs of the
TGA and are subject to full cost recovery from industry," the
spokesperson said.
TGA HQ is owned by Cromwell TGA Managed Investment, a unit
trust opreated by Brisbane-based company Cromwell Securities
which bought it from the Commonwealth for $50.1 million in
2002. At the time of the purchase the unit holders were former
Packer executive Trevor Kennedy, Ozemail founder Sean Howard
and the current Liberal member for Wentworth, Malcolm Turnbull.
In September last year, the Australian Financial Review reported
that Kennedy and Howard had sold out of the trust in a deal
that netted them a $20 million profit and valued the building
at around $80 million. By that time, Mr Turnbull had transferred
his interest to his wife Lucy.
The newspaper added that Cromwell had sought to increase
the rent to $7 million, a figure that was under review by
an independent valuer.
The final rent increase was revealed to industry representatives
at a TGA Industry Consultative Council meeting in November
last year.
15th Jan 2006
Be Wary of the ‘Instant
Experts’
There is currently a significant amount of inaccurate and
misleading information circulating on the internet about
Codex and other related health freedom issues. Whilst some
of the authors of this material claim to have carefully studied
more than 16,000 pages of Codex documentation, the content
of their articles and the nature of their proposed strategies
strongly suggests otherwise. The following article may help
you to sort the facts from the fiction. read
full article click here
3rd Jan 2006
The 2005 meeting of the Codex Committee
on Nutrition and Foods for Special Dietary Uses (CCNFSDU)
took place from 21-25 November, in Bonn, Germany, and was
attended by 315 delegates representing 68 countries and 33
international organizations.
Any doubts as to whether or not Codex is concerned about
its loss of trust and respect amongst consumers were immediately
dispelled by the Committee's infamous Chairman, Dr. Rolf
Grossklaus, who opened the meeting by stating that the Committee
had to improve its public relations image. read
full story click here
Please
click here to join our list to receive our Newsletter
We encourage you to join our mailing list so you can be kept
informed.
You can unsubscribe at any time and we never share your information
with any one. You will likely receive one email per month
unless there is an urgent message to convey. We hope you
will enjoy the Newsletter - Thank you!